Regeneron Pharmaceuticals, Inc. patent applications published on July 25th, 2024
Contents
- 1 Patent applications for Regeneron Pharmaceuticals, Inc. on July 25th, 2024
- 1.1 METHODS OF MODELING LIQUID PROTEIN COMPOSITION STABILITY (18420955)
- 1.2 METHODS OF TREATING CANCER PAIN BY ADMINISTERING A PD-1 INHIBITOR (18438746)
- 1.3 FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF (18412280)
- 1.4 Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A (17415589)
- 1.5 Treatment Of Stroke With 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Inhibitors (18421326)
- 1.6 MASS SPECTROMETRY-BASED CHARACTERIZATION OF ANTIBODIES CO-EXPRESSED IN VIVO (18422188)
- 1.7 SYSTEMS AND METHODS FOR MOBILE AND STATIC BIOMETRIC MOVEMENT TRACKING (18420090)
Patent applications for Regeneron Pharmaceuticals, Inc. on July 25th, 2024
METHODS OF MODELING LIQUID PROTEIN COMPOSITION STABILITY (18420955)
Main Inventor
Douglas E. KAMEN
METHODS OF TREATING CANCER PAIN BY ADMINISTERING A PD-1 INHIBITOR (18438746)
Main Inventor
Chieh-I Chen
FGFR3 BINDING MOLECULES AND METHODS OF USE THEREOF (18412280)
Main Inventor
Yan YANG
Compositions and Methods for Enhancing Body Weight and Lean Muscle Mass Using Antagonists Against Leptin Receptor, GDF8 and Activin A (17415589)
Main Inventor
Judith Altarejos
Treatment Of Stroke With 1,4-Alpha-Glucan-Branching Enzyme (GBE1) Inhibitors (18421326)
Main Inventor
Neelroop Parikshak
MASS SPECTROMETRY-BASED CHARACTERIZATION OF ANTIBODIES CO-EXPRESSED IN VIVO (18422188)
Main Inventor
Yuetian Yan
SYSTEMS AND METHODS FOR MOBILE AND STATIC BIOMETRIC MOVEMENT TRACKING (18420090)
Main Inventor
Matthew F. WIPPERMAN
